The U.S. Food and Drug Administration (FDA) has proposed a new rule aimed at modernizing how drug manufacturers register their facilities and list their products. The proposed regulation seeks to …
PHAR
-
-
Medicare Expands Coverage for GLP-1 Weight Loss Drugs Amid Rising Demand Medicare will begin covering GLP-1 (glucagon-like peptide-1) weight loss medications for eligible seniors starting in 2024, with a $50 …
-
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the revocation of the marketing authorization for Tavneos (avacopan), an Amgen-manufactured treatment for severe active …
-
Understanding Pharmaceutical Patent Protection: Balancing Innovation and Access The pharmaceutical industry operates on a complex foundation of intellectual property law. At the heart of this system is the patent, a …
-
Sandoz Files Anti-Dumping Complaint Regarding Chinese Antibiotics The pharmaceutical landscape is currently navigating a significant shift in trade policy as Sandoz, a global leader in generic and biosimilar medicines, has …